Zobrazeno 1 - 10
of 492
pro vyhledávání: '"Steven D. Nathan"'
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 18 (2024)
Background: A six-minute walk test (6MWT) is a reproducible, easily performed test, and is widely used to determine functional exercise capacity in patients with idiopathic pulmonary fibrosis (IPF). However, there is currently a paucity of data on th
Externí odkaz:
https://doaj.org/article/ee4b240bcb0e46a4813372a1f9587f3f
Autor:
Michael B. Keller, MD, Junfeng Sun, PhD, Muhtadi Alnababteh, MD, Lucia Ponor, MD, Pali D. Shah, MD, Joby Mathew, DPT, Hyesik Kong, PhD, Ananth Charya, MD, Helen Luikart, RN, Shambhu Aryal, MD, Steven D. Nathan, MD, Jonathan B. Orens, MD, Kiran K. Khush, MD, Moon Kyoo Jang, PhD, Sean Agbor-Enoh, MD
Publikováno v:
Transplantation Direct, Vol 10, Iss 7, p e1669 (2024)
Background. A prior single-center, retrospective cohort study identified baseline lung allograft dysfunction (BLAD) as a risk factor for death in bilateral lung transplant recipients. In this multicenter prospective cohort study, we test the associat
Externí odkaz:
https://doaj.org/article/7cbc23ee4d4d424099dba7f7eda10cf5
Autor:
Tracey Weiss, Aimee M. Near, Xiaohui Zhao, Dena Rosen Ramey, Tania Banerji, Handing Xie, Steven D. Nathan
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Rationale There is a lack of real-world characterization of healthcare costs and associated cost drivers in patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease (PH-COPD). Objectives To examine (1) excess h
Externí odkaz:
https://doaj.org/article/3ddd0f0dabfb4c3295ffd4fa37824637
Autor:
Tracey Weiss, Dena R. Ramey, Ngan Pham, Nazneen Fatima Shaikh, Dajun Tian, Xiaohui Zhao, Aimee M. Near, Dominik Lautsch, Steven D. Nathan
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 2, Pp n/a-n/a (2024)
Abstract This retrospective study was conducted to evaluate all‐cause healthcare resource utilization (HCRU) and costs in commercially insured patients living with pulmonary arterial hypertension (PAH) and explore end‐of‐life (EOL)‐related HC
Externí odkaz:
https://doaj.org/article/e1731666b6cb444782d67050c24c44a5
Autor:
Steven D. Nathan, Benham Tehrani, Qiong Zhao, Rafael Arias, Dennis Kim, Antonia Pellegrini, Ashley Claire Collins, Jack Diviney, Shourjo Chakravorty, Vikramjit Khangoora, Oksana A. Shlobin, Christopher Thomas, Ben R. Lavon, Christopher S. King, Abhimanyu Chandel
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 1, Pp n/a-n/a (2024)
Abstract Pulmonary vascular dysfunction in the absence of pulmonary hypertension (PH) has been observed in patients with idiopathic pulmonary fibrosis (IPF). We describe the prevalence and etiology of elevated pulmonary vascular resistance (PVR) with
Externí odkaz:
https://doaj.org/article/0736e46afbbf4357b8d2aa58730cdf0c
Autor:
Oksana A. Shlobin, Eric Shen, Stephen J. Wort, Lucilla Piccari, John A. Scandurra, Paul M. Hassoun, Sylvia M. Nikkho, Steven D. Nathan
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 1, Pp n/a-n/a (2024)
Abstract Pulmonary hypertension (PH) due to interstitial lung disease (ILD), a commonly encountered complication of fibrotic ILDs, is associated with significant morbidity and mortality. Until recently, the studies of pulmonary vasodilator therapy in
Externí odkaz:
https://doaj.org/article/9ed23c30ba194e9489b223bcf9cea4b7
Autor:
Paul Ford, Michael Kreuter, Kevin K. Brown, Wim A. Wuyts, Marlies Wijsenbeek, Dominique Israël-Biet, Richard Hubbard, Steven D. Nathan, Hilario Nunes, Bjorn Penninckx, Niyati Prasad, Ineke Seghers, Paolo Spagnolo, Nadia Verbruggen, Nik Hirani, Juergen Behr, Robert J. Kaner, Toby M. Maher
Publikováno v:
ERJ Open Research, Vol 10, Iss 1 (2024)
Background There is no standard definition of respiratory-related hospitalisation, a common end-point in idiopathic pulmonary fibrosis (IPF) clinical trials. As diverse aetiologies and complicating comorbidities can present similarly, external adjudi
Externí odkaz:
https://doaj.org/article/dd10a57961ca4f14aca9968ef542372a
Autor:
Shameek K. Gayen, Robert P. Baughman, Steven D. Nathan, Athol U. Wells, Vasilis Kouranos, Esam H. Alhamad, Daniel A. Culver, Joseph Barney, Eva M. Carmoma, Francis C. Cordova, Marloes Huitema, Mary Beth Scholand, Marlies Wijsenbeek, Sivagini Ganesh, Surinder S. Birring, Laura C. Price, Stephen J. Wort, Oksana A. Shlobin, Rohit Gupta
Publikováno v:
Pulmonary Circulation, Vol 13, Iss 4, Pp n/a-n/a (2023)
Abstract Pulmonary hypertension (PH) is a risk factor for mortality in patients with sarcoidosis. Severe PH in chronic lung disease has previously been defined as mean pulmonary arterial pressure (mPAP) ≥ 35 mmHg or mPAP 25 ≥ mmHg with cardiac in
Externí odkaz:
https://doaj.org/article/bc4ee1dfe8b84f39af2bd487660885c1
Autor:
Christopher S. King, Emily White, Shambhu Aryal, Oksana A. Shlobin, Anju Singhal, A. Whitney Brown, Christopher Thomas, Vikramjit Khangoora, Alan Nyquist, Kevin R. Flaherty, Steven D. Nathan, Joshua J. Mooney
Publikováno v:
Heliyon, Vol 9, Iss 8, Pp e18618- (2023)
Rationale and objectives: Lung transplantation is a potentially life-saving treatment option for patients with idiopathic pulmonary fibrosis (IPF); however, not all eligible candidates get referred and listed for transplantation. Amongst IPF patients
Externí odkaz:
https://doaj.org/article/8c37b2bb0a4644b09df9db233129b2fc
Autor:
Toby M. Maher, Courtney Schiffman, Michael Kreuter, Catharina C. Moor, Steven D. Nathan, Judit Axmann, Paula Belloni, Monica Bengus, Frank Gilberg, Klaus-Uwe Kirchgaessler, Marlies S. Wijsenbeek
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-12 (2022)
Abstract Background Patients with interstitial lung disease (ILD) require regular physician visits and referral to specialist ILD clinics. Difficulties or delays in accessing care can limit opportunities to monitor disease trajectory and response to
Externí odkaz:
https://doaj.org/article/e408398a513e4a71a24021b423960045